Stay updated on Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial

Sign up to get notified when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The history page now displays Revision: v3.6.6 instead of Revision: v3.6.5, reflecting a small software update.
    Difference
    0.1%
    Check dated 2026-09-01T20:55:34.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A newer revision label v3.6.5 appears in the history, replacing the previous revision v3.6.4. This indicates a page version update rather than changes to the study data or descriptions.
    Difference
    0.1%
    Check dated 2026-08-11T18:31:15.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Version 28 was submitted on 2026-07-06, updating the study record with changes to key sections such as Adverse Events, Baseline Characteristics, Outcome Measures, and Study Status. A subsequent 2026-07-29 entry indicates the record was Returned with a Quality Control Review Has Not Concluded, highlighting ongoing QC on the latest data.
    Difference
    0.6%
    Check dated 2026-08-04T15:00:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The study history page now shows a new site revision, v3.6.4, in place of the previous v3.6.3. This appears to be a front-end update to the page and does not modify the trial's records or content.
    Difference
    0.1%
    Check dated 2026-07-28T14:40:49.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The revision history now lists a new revision (v3.6.3) and removes the older v3.6.0 entry, updating the shown list of revisions for the record.
    Difference
    0.1%
    Check dated 2026-06-29T20:15:39.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    A new version (v3.6.0) was added to the study record, including a note that no longer looking for participants and a QC status of Has Not Concluded. The update also introduces several sections (More Information, Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, References, Contacts/Locations) with the 2026-05-18 date and revision 27, replacing the prior revision v3.5.5.
    Difference
    1%
    Check dated 2026-06-15T12:48:11.000Z thumbnail image

Stay in the know with updates to Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.